Promising effects beyond weight loss Researchers are currently studying the effect of GLP-1s on a wide range of conditions beyond diabetes, obesity, and heart disease, including renal, hepatic, neurological, and substance-use disorders
Previous data from the study using AMRA Researcher, demonstrated that patients treated with tirzepatide showed, in addition to the significant weight reduction, a favorable effect on fat distribution pattern (visceral fat, subcutaneous fat and liver fat)
It could inhibit ferroptosis and protect against kidney injury by reducing ROS production, mitigating the inflammatory response and alleviating mitochondrial damage through the adiponectin receptor 1 (AdipoR1)/AMPK/Nrf2/HO-1/GPX4 pathway in HFD/STZ-induced diabetic mice[165]
Its like having your own consultant along your semaglutide journey. Semaglutide changes your relationship with food With semaglutide, the body and brain feel fuller faster, helping prevent overeating
I mean, you and I have had plenty of conversations off the record